Versant Ventures
Steven Edelson currently serves as Vice President of Investor Relations and Communications at Versant Ventures, a position held since October 2016, following roles as Senior Director and Director within the same department. Prior to joining Versant Ventures, Steven Edelson was employed at BioCentury Publications Inc. from September 1998 to October 2016, where contributions included serving as Senior Editor in Finance. Steven Edelson holds a Master's degree in Biotechnology from Northwestern University, obtained between 1993 and 1998.
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.